Study of Risk Factors and Prediction of Blood Clots After Lung Cancer Surgery
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorThe First Hospital of Jilin University
About this trial
The goal of this observational study is to learn about the risk factors and prediction of postoperative venous thromboembolism (VTE) in patients undergoing lung cancer surgery. The main question it aims to answer is:
Which clinical, surgical, and laboratory factors are associated with the development of postoperative deep vein thrombosis (DVT) in lung cancer surgery patients, and can machine learning models accurately predict individual risk?
Participants undergoing lung cancer surgery will be prospectively followed for 30 days after surgery. Perioperative clinical data, laboratory results, and imaging findings will be collected to identify VTE risk factors and to develop a predictive model.
Eligibility criteria
Qualifiers
Age ≥ 18 years
Patients undergoing surgical resection for lung cancer
Postoperative hospital stay ≥ 48 hours
Availability of perioperative clinical, laboratory, and imaging data
Disqualifiers
Pre-existing deep vein thrombosis (DVT) or pulmonary embolism (PE) before surgery
Preoperative or ongoing anticoagulation therapy for ≥ 2 weeks
Severe coagulation disorders or bleeding diseases
Severe hepatic, renal, or hematologic dysfunction, or uncontrolled systemic infection
Trial design
Treatments tested in this trial
- Prospective Perioperative Data Collection
Treatment groups
900 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov